Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

IonSense and Cerno Bioscience Introduce Low Cost DART® Mass Spectrometer With Accurate Mass Capability

Published: Tuesday, July 02, 2013
Last Updated: Monday, July 01, 2013
Bookmark and Share
Cerno's Novel MS Calibration Technology, Integrated With the DART GSX Equipped Agilent 5975 MSD, Enables Accurate Mass Assignment of Intact Protonated Molecules

IonSense, Inc. and Cerno Bioscience, LLC today announce the integration of Cerno's MassWorks™ software with the DART® GSX system, recently introduced at Pittcon 2013. The IonSense DART GSX system enables ambient pressure ionization on the very popular Agilent 5975 GC/MSD. Utilizing Cerno's patented calibration technology the DART GSX delivers accurate mass assignments in seconds at less than half the cost of industry standard high resolution mass spectrometers. The capability to confirm mass values for intact ionized molecules address the unmet needs of QA/QC chemists in a variety of industries served by the Agilent MSD product, such as food safety, forensics, and chemical analysis.

This combination of innovative products reduces the cost of acquisition of an accurate screening instrument to under $100,000. IonSense currently supplies its popular DART-SVP source for use with high resolution mass spectrometers from all of the LC/MS vendors. "Many laboratories in the food, fragrance and forensic analysis business would like to have a high performance LC/MS instrument," according to Brian Musselman, President of IonSense, "those systems just cost too much and use lots of organic solvents adding to operating costs." Direct analysis in real time (DART) technology saves time by eliminating significant sample prep, and is useful for rapid screening of samples with most analysis requiring only a few seconds.

Cerno BioScience has supplied its award winning MassWorks software for over 6 years according to company Founder and President Yongdong Wang, Ph.D. The software uniquely determines accurate mass elemental composition on a quadrupole MS through 100x improvement in mass accuracy and the novel concept of spectral accuracy.

The companies co-market the product, offering the Cerno software and follow-up training program to all customers who purchase the DART GSX. As people come to know the value of accurate mass, Musselman expects a rapid expansion of the market for the Cerno / IonSense product, "Basically there is nothing like an accurate mass value to confidently determine a compound."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent to Distribute Cerno's Calibration and Analysis Software with GC/MSD Systems
Novel Program Increases Lab Accuracy and Unknown Compound Identification with Single Quadrupole Instrumentation
Thursday, June 19, 2014
Scientific News
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Spotting DNA Repair Genes Gone Awry
Ludwig researchers develop a two-pronged approach for identifying genes responsible for fixing DNA damage that can trigger cancer when compromised.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!